Literature DB >> 15145148

Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.

Susan L Tucker1, Rex Cheung, Lei Dong, H Helen Liu, Howard D Thames, Eugene H Huang, Deborah Kuban, Radhe Mohan.   

Abstract

PURPOSE: To compare the fits of various normal tissue complication probability (NTCP) models to a common set of late rectal toxicity data, with the aim of identifying the best model for predicting late rectal injury after irradiation. METHODS AND MATERIALS: Late toxicity data from 128 prostate cancer patients treated on protocol with three-dimensional conformal radiotherapy at The University of Texas M.D. Anderson Cancer Center (UTMDACC) were analyzed. The dose-volume histogram for total rectal volume, including contents, was obtained for each patient, and the presence or absence of Grade 2 or worse rectal bleeding within 2 years of treatment was scored. Five different NTCP models were fitted to the data using maximum likelihood analysis: the Lyman model, the mean dose model, a parallel architecture model, and models based on either a cutoff dose or a cutoff volume.
RESULTS: All five of the NTCP models considered provided very similar fits to the UTMDACC rectal bleeding data. In particular, none of the more highly parameterized models (the four-parameter parallel model, three-parameter Lyman model, or three-parameter cutoff dose and volume models) provided a better fit than the simplest of the models, the two-parameter NTCP model describing rectal bleeding as a probit function of mean dose to rectum.
CONCLUSION: No dose-volume response model has yet been identified that provides a better description of the UTMDACC rectal toxicity data than the mean dose model. Because this model has relatively low predictive accuracy, the need to identify a better model remains.

Entities:  

Mesh:

Year:  2004        PMID: 15145148     DOI: 10.1016/j.ijrobp.2003.12.033

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Authors:  Matthias Söhn; Di Yan; Jian Liang; Elisa Meldolesi; Carlos Vargas; Markus Alber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-26       Impact factor: 7.038

2.  A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study.

Authors:  M Fatyga; J F Williamson; N Dogan; D Todor; J V Siebers; R George; I Barani; M Hagan
Journal:  Med Phys       Date:  2009-09       Impact factor: 4.071

3.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.

Authors:  M Rex Cheung; Susan L Tucker; Lei Dong; Renaud de Crevoisier; Andrew K Lee; Steven Frank; Rajat J Kudchadker; Howard Thames; Radhe Mohan; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

4.  Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.

Authors:  Haruo Inokuchi; Takashi Mizowaki; Yoshiki Norihisa; Kenji Takayama; Itaru Ikeda; Kiyonao Nakamura; Mitsuhiro Nakamura; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2015-07-12       Impact factor: 3.402

5.  Metabolic imaging biomarkers of postradiotherapy xerostomia.

Authors:  Blake Cannon; David L Schwartz; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-30       Impact factor: 7.038

Review 6.  Reducing rectal injury during external beam radiotherapy for prostate cancer.

Authors:  Riccardo Valdagni; Tiziana Rancati
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

Review 7.  Intensity-modulated radiation therapy: emerging cancer treatment technology.

Authors:  T S Hong; M A Ritter; W A Tomé; P M Harari
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

8.  Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.

Authors:  Simona Marzi; Biancamaria Saracino; Maria G Petrongari; Stefano Arcangeli; Sara Gomellini; Giorgio Arcangeli; Marcello Benassi; Valeria Landoni
Journal:  J Exp Clin Cancer Res       Date:  2009-08-19

9.  Comparison of dose response models for predicting normal tissue complications from cancer radiotherapy: application in rat spinal cord.

Authors:  Magdalena Adamus-Górka; Panayiotis Mavroidis; Bengt K Lind; Anders Brahme
Journal:  Cancers (Basel)       Date:  2011-05-18       Impact factor: 6.639

10.  Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).

Authors:  Aime M Gloi; Robert Buchanan
Journal:  J Appl Clin Med Phys       Date:  2013-01-07       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.